Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder

NCT07102524 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
2
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

TESS Research Foundation